Mechanism of Action MT2 exerts its activity by acting as an agonist at melanocortin receptors distributed throughout the body and brain
User 16, a 68-year-old woman bedridden with L5 spinal stenosis and scoliosis, used an unusually high BPC-157 dose of 2.5mg daily alongside 200mcg TB-500 daily, transitioning the TB-500 to every third day after two weeks
doi: 10.1002/jps.20155 23 MondalSMugeshG
Because GLP-1 medications deliver much higher levels of the hormone than the body naturally produces in the joints, researchers believe these drugs could potentially affect inflammation in those tissues
The findings of this work clearly indicate that ALC has a neurotherapeutic impact in a 6-OHDA-mediated model of PD by inhibiting apoptosis, neuroinflammation, astrogliosis, and OS, and that it might be considered as a potential supplementary treatment option for PD management (Afshin-Majd et al., 2017)